IP Library Patent Application 15343371
Patent Application
App. No. 15/343,371

GUM RESIN AS A CARRIER FOR TOPICAL APPLICATION OF PHARMACOLOGICALLY ACTIVE AGENTS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/343,371
Abstract

Described are pharmacological compositions comprising a gum resin; a pharmacologically active agent and a topically acceptable volatile solvent for the gum resin and active agent. Also described are methods for the transdermal or transmucosal delivery of a pharmacologically active agent using such compositions.

Claims (14)

1 - 32 . (canceled)

1 . A liquid pharmacological composition comprising:

(a) a gum resin;

(b) an active agent selected from the group consisting of nicotine, nitroglycerin and scopolamine; and

(c) a topically acceptable volatile solvent for said gum resin and said active agent in an amount of about 40% to 90% of said composition.

34 . The composition according to claim 33 , wherein said gum resin is selected from the group consisting of benzoin gum and mastic gum.

35 . The composition according to claim 33 , wherein said topically acceptable volatile solvent comprises 40% to 90% of said composition.

36 . The composition according to claim 33 , wherein said topically acceptable volatile solvent comprises ethanol.

37 . The composition according to claim 36 , wherein said topically acceptable volatile solvent comprises about 60% to 90% of said composition.

38 . The composition according to claim 33 , further comprising a penetration. enhancer.

39 . The composition according to claim 33 , wherein the composition is formulated for transmucosal administration.

40 . The composition according to claim 33 , wherein the active agent is nicotine.

41 . The composition according to claim 33 , wherein the active agent is nitroglycerin.

42 . The composition according to claim. 33 , wherein the active agent is scopolamine.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY PREVIOUSLY RECORDED AT REEL: 046087 FRAME: 0363. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 21, 2018
From: JALEVA PHARMACEUTICALS, LLC
To: ADVANCED RESIN THERAPEUTICS, INC.
Reel/Frame 046407/0441 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2018
From: JAVELA PHARMACEUTICALS, LLC
To: ADVANCED RESIN THERAPEUTICS, INC.
Reel/Frame 046087/0363 →